TY - JOUR
T1 - Epigallocatechin gallate has pleiotropic effects on transmembrane signaling by altering the embedding of transmembrane domains
AU - Ye, Feng
AU - Yang, Chansik
AU - Kim, Jiyoon
AU - MacNevin, Christopher J.
AU - Hahn, Klaus M.
AU - Park, Dongeun
AU - Ginsberg, Mark H.
AU - Kim, Chungho
N1 - Funding Information:
This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (Grant NRF-2016R1A2B4009755) (to C. K.), by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (Grant HI14C0209) (to C. K.), and by National Institutes of Health Grants CA-142833 and P41-EB002025 (to K. M. H.) and HL 078784 and HL 117807 (to M. H. G.).
Publisher Copyright:
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.
PY - 2017/6/16
Y1 - 2017/6/16
N2 - Epigallocatechin gallate (EGCG) is the principal bioactive ingredient in green tea and has been reported to have many health benefits. EGCG influences multiple signal transduction pathways related to human diseases, including redox, inflammation, cell cycle, and cell adhesion pathways. However, the molecular mechanisms of these varying effects are unclear, limiting further development and utilization of EGCG as a pharmaceutical compound. Here, we examined the effect of EGCG on two representative transmembrane signaling receptors, integrin αIIbβ3 and epidermal growth factor receptor (EGFR). We report that EGCG inhibits talin-induced integrinαIIbβ3 activation, but it activates αIIbβ3 in the absence of talin both in a purified system and in cells. This apparent paradox was explained by the fact that the activation state ofαIIbβ3 is tightly regulated by the topology ofβ3 transmembrane domain (TMD); increases or decreases in TMD embedding can activate integrins. Talin increases the embedding of integrinβ3 TMD, resulting in integrin activation, whereas we observed here that EGCG decreases the embedding, thus opposing talin-induced integrin activation. In the absence of talin, EGCG decreases the TMD embedding, which can also disrupt the integrinα-β TMDinteraction, leading to integrin activation. EGCG exhibited similar paradoxical behavior in EGFR signaling. EGCG alters the topology of EGFR TMD and activates the receptor in the absence of EGF, but inhibits EGF-induced EGFR activation. Thus, this widely ingested polyphenol exhibits pleiotropic effects on transmembrane signaling by modifying the topology of TMDs.
AB - Epigallocatechin gallate (EGCG) is the principal bioactive ingredient in green tea and has been reported to have many health benefits. EGCG influences multiple signal transduction pathways related to human diseases, including redox, inflammation, cell cycle, and cell adhesion pathways. However, the molecular mechanisms of these varying effects are unclear, limiting further development and utilization of EGCG as a pharmaceutical compound. Here, we examined the effect of EGCG on two representative transmembrane signaling receptors, integrin αIIbβ3 and epidermal growth factor receptor (EGFR). We report that EGCG inhibits talin-induced integrinαIIbβ3 activation, but it activates αIIbβ3 in the absence of talin both in a purified system and in cells. This apparent paradox was explained by the fact that the activation state ofαIIbβ3 is tightly regulated by the topology ofβ3 transmembrane domain (TMD); increases or decreases in TMD embedding can activate integrins. Talin increases the embedding of integrinβ3 TMD, resulting in integrin activation, whereas we observed here that EGCG decreases the embedding, thus opposing talin-induced integrin activation. In the absence of talin, EGCG decreases the TMD embedding, which can also disrupt the integrinα-β TMDinteraction, leading to integrin activation. EGCG exhibited similar paradoxical behavior in EGFR signaling. EGCG alters the topology of EGFR TMD and activates the receptor in the absence of EGF, but inhibits EGF-induced EGFR activation. Thus, this widely ingested polyphenol exhibits pleiotropic effects on transmembrane signaling by modifying the topology of TMDs.
UR - http://www.scopus.com/inward/record.url?scp=85020856264&partnerID=8YFLogxK
U2 - 10.1074/jbc.C117.787309
DO - 10.1074/jbc.C117.787309
M3 - Article
C2 - 28487468
AN - SCOPUS:85020856264
SN - 0021-9258
VL - 292
SP - 9858
EP - 9864
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 24
ER -